Revenue Grows 20%, but a 49.8% Gross Margin Breaks the Operating-Leverage Case
Key Takeaways
- Growth continued, but gross margin fell to 49.8%. Q3 revenue rose 20.3% to $7.485 million and beat both estimate panels. Gross margin fell 1,060bp from Q2 and 1,100bp from a year ago, and the call gave no specific cause.
- GAAP profit now depends on a tax benefit. SuperCom reported an operating loss of ($0.289 million), and a $0.670 million deferred-tax benefit produced the $54 thousand of net income. Over nine months, the company's currency addback of $3.520 million was nearly twice GAAP operating profit.
- Cash conversion is still the unanswered test. Current and long-term trade receivables total $28.0 million, about 91% of trailing revenue, and FY2025 operating cash flow was ($5.49 million). Excluding the July offering, Q3 cash use was about $1.6 million to $1.9 million, a slower decline than in H1.
- Rating: Maintaining Hold. The shares fell 28.4% in two sessions to $6.17, about 1.04 times tangible book and 0.70 times total book. Our base value falls to $7.00 from $11.31, and the margin and cash questions keep us from upgrading on price alone.
Results vs. Consensus
Q3 FY2026 Scorecard
For the three months ended September 30, 2026, revenue exceeded both available estimate panels. The panels disagree, so we show the range rather than one consensus figure. Both panels had expected Q3 revenue to come in below Q2. We found no EPS estimate that meets our two-source standard, so we do not score non-GAAP EPS against a consensus. Dollar amounts are U.S. dollars.
| Metric | Q3 2026 actual | Estimate range | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $7.485M | $6.95M–$7.20M | Beat | +4.0% to +7.7% |
| GAAP gross margin | 49.8% | n/a | Below Q2 and Q3 2025 | -1,060bp QoQ; -1,100bp YoY |
| GAAP operating income | ($0.289M) | n/a | Loss | Versus $0.639M a year ago |
| GAAP EPS | $0.01 | n/a | Down YoY | Versus $0.14 a year ago |
| Non-GAAP EPS | $0.30 | n/a | No reliable consensus | Versus $0.39 a year ago |
| Company-defined EBITDA | $2.575M | n/a | No estimate | +19.6% YoY |
| Free cash flow | Not disclosed | n/a | n/a | No cash-flow statement in the release |
Year-Over-Year Comparison: Q3
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $7.485M | $6.224M | +20.3% |
| Cost of revenues | $3.759M | $2.441M | +54.0% |
| Gross profit | $3.726M | $3.783M | -1.5% |
| GAAP gross margin | 49.8% | 60.8% | -1,100bp |
| Research and development | $0.933M | $0.882M | +5.8% |
| Selling and marketing | $1.076M | $0.634M | +69.7% |
| General and administrative | $1.866M | $1.496M | +24.7% |
| Total operating expenses | $4.015M | $3.144M | +27.7% |
| Operating income (loss) | ($0.289M) | $0.639M | n/m |
| Financial income (expense), net | ($0.327M) | $0.052M | n/m |
| Pretax income (loss) | ($0.616M) | $0.691M | n/m |
| Income tax benefit | $0.670M | Nil | n/m |
| Net income | $0.054M | $0.691M | -92.2% |
| GAAP EPS | $0.01 | $0.14 | n/m |
| Non-GAAP net income | $1.867M | $1.900M | -1.7% |
| Non-GAAP EPS | $0.30 | $0.39 | -23.1% |
| Company-defined EBITDA | $2.575M | $2.153M | +19.6% |
The release headline cites 21% revenue growth. The statement amounts give 20.3%, and we use the statement figure throughout.
Sequential Comparison: Q3 vs. Q2
| Metric | Q3 2026 | Q2 2026 | QoQ change |
|---|---|---|---|
| Revenue | $7.485M | $8.088M | -7.5% |
| Cost of revenues | $3.759M | $3.205M | +17.3% |
| Gross profit | $3.726M | $4.883M | -23.7% |
| GAAP gross margin | 49.8% | 60.4% | -1,060bp |
| Total operating expenses | $4.015M | $4.025M | -0.2% |
| Operating income (loss) | ($0.289M) | $0.858M | n/m |
| Net income | $0.054M | $1.107M | -95.1% |
| Non-GAAP net income | $1.867M | $2.888M | -35.4% |
| Non-GAAP EPS | $0.30 | $0.52 | -42.3% |
| Company-defined EBITDA | $2.575M | $3.951M | -34.8% |
Q2 cost of revenues is revenue less gross profit from the Q2 statement. Gross margins are calculated from the statement dollars.
Nine-Month Context: Nine Months Ended September 30
| Metric | 9M 2026 | 9M 2025 | YoY change |
|---|---|---|---|
| Revenue | $23.185M | $20.412M | +13.6% |
| Gross profit | $13.411M | $12.461M | +7.6% |
| GAAP gross margin | 57.8% | 61.0% | -320bp |
| Total operating expenses | $11.615M | $9.504M | +22.2% |
| Operating profit | $1.796M | $2.957M | -39.3% |
| Financial income (expense), net | ($1.070M) | $3.054M | n/m |
| Income tax benefit | $1.760M | Nil | n/m |
| GAAP net income | $2.486M | $6.011M | -58.6% |
| Non-GAAP net income | $7.538M | $9.325M | -19.2% |
| Company-defined EBITDA | $9.865M | $7.219M | +36.7% |
The 2025 base includes extraordinary financial gains of about $4.1 million in H1 2025. Even without that distortion, the nine-month pattern is clear: company-defined EBITDA rose 36.7% while GAAP operating profit fell 39.3%. The gap between the two measures is now the central issue for the stock.
Revenue assessment: Year-over-year growth continued to accelerate, from about 8% in Q1 and 13.3% in Q2 to 20.3% in Q3. The comparison was easy, because Q3 2025 revenue had fallen year over year. Sequentially, revenue fell 7.5%, and the estimate panels had expected that decline. For our own forecast, the problem is a 13.5% shortfall against the $8.65 million a quarter that our Q2 estimate needed for H2.
Margin assessment: Gross profit fell $1.157 million from Q2 while revenue fell $0.603 million. Cost of revenues rose 17.3% sequentially on lower sales. Operating expenses were flat with Q2 at $4.015 million, so the whole gross-profit decline reached operating income. The quarter does not show the operating leverage that the release describes.
Earnings assessment: The pretax loss was ($0.616 million). A $0.670 million tax benefit, the same amount as in Q2, turned it into $54 thousand of net income. Non-GAAP net income was flat year over year, but non-GAAP EPS fell 23.1% because of the larger share count. Per-share dilution from the July offering is now visible in the adjusted figures.
What the Q3 EBITDA Figure Contains
| Q3 2026 reconciliation | Amount |
|---|---|
| GAAP net income | $0.054M |
| Add net financial expense | $0.327M |
| Remove income tax benefit | ($0.670M) |
| Add depreciation and amortization | $1.035M |
| Subtotal before company adjustments | $0.746M |
| Add stock-based compensation | $0.340M |
| Add foreign-currency loss | $1.349M |
| Add other one-time expenses | $0.140M |
| Company-defined EBITDA | $2.575M |
The three company adjustments total $1.829 million, or 71.0% of reported EBITDA. The currency item alone is 52.4%. The release reconciliation adds the currency loss to operating profit but not to gross profit, so the company's own tables place it in operating expenses. The release does not name the line.
Business-Line Performance
SuperCom's annual report identifies three reportable segments, but the quarterly release gives no business-line revenue or profit split. The table below therefore uses operating disclosures, not segment financials. Electronic monitoring (EM) inside the IoT business remains the growth driver.
| Business / market | Q3 and call-date evidence | Investment implication |
|---|---|---|
| U.S. EM technology | Quarterly recurring revenue up about 255% YoY; more than 50 contracts and 21 new states since mid-2024 | Installed base is growing fast; dollar size still undisclosed |
| European EM | Ministry of Justice orders over $3 million (announced in July); Sweden launched; England and Italy bids ahead | Large orders lift revenue unevenly and add long-term receivables |
| LCA reentry services | No Q3 LCA revenue given; California contract figures repeated from Q2 | Supports U.S. agency relationships; no separate growth assumed |
| Cybersecurity (Safend, SafeGenie) | SafeGenie introduced in October; Safend endpoint-security revenue roughly $1 million | Optionality; no revenue in our estimates |
| e-Government | No Q3 disclosure | No growth assumed |
U.S. Electronic Monitoring: Wins Keep Coming, Mostly by Displacement
The U.S. business added contracts in Indiana, Illinois, Utah, Texas, Ohio, New York, Kansas and Michigan during the quarter, plus a contract with a large Georgia-based service provider. Two more Texas contracts and a seventh New York contract followed after the quarter. Management says many of these wins replaced long-standing incumbents. The U.S. footprint now reaches 21 new states since mid-2024, with access to more states through 18 regional service-provider partnerships.
"Every one of our five Texas contracts to date has involved replacing an incumbent provider." — Ordan Trabelsi, President & CEO
Quarterly U.S. recurring revenue grew about 255% year over year, after 88% in Q1 and 171% in Q2. Contract sizes are also larger, at 100 to 250 simultaneous units and more for recent wins. Full deployment can take six months or more, so the Q3 and October wins are likely to affect mainly 2027 revenue.
Assessment: The U.S. evidence remains the strongest part of the thesis. It is also the part we can measure least well, because the company still gives growth rates without dollar levels. We cannot tell how much of consolidated revenue the U.S. recurring base now represents.
European Electronic Monitoring: Orders Arrive in Steps
Q3 included Ministry of Justice orders of more than $3 million from an existing customer, which the company first announced in July, and the Swedish national program is live. Management explained that large European device orders are recognized up front and collected over the program's life. Romania remains active, but at lower order levels than in prior periods.
"As a result, quarters with large orders can show a step-up in revenue, while the related cash comes in steadily over time." — Ordan Trabelsi, President & CEO
"The program remains active, but temporary decline in Romania masked strong growth across the rest of the electronic monitoring business." — Ordan Trabelsi, President & CEO
Assessment: The European model explains both the revenue volatility and the long-term receivables build. It also means European revenue growth does not convert to cash in the same period. We continue to treat Europe as the source of the large step-ups, and we model it with a lag between revenue and collections.
LCA Reentry Services
LCA, the California subsidiary, provides reentry and probation services next to the monitoring technology. As on the Q2 call, management said that SuperCom has won more than $35 million of new California contracts since the acquisition. No Q3 revenue figure was given for LCA.
"These services allow us to address additional compliance and rehabilitation needs alongside our monitoring technology." — Ordan Trabelsi, President & CEO
Assessment: LCA strengthens the relationship with California agencies. It is a services business with different economics from EM technology, and we give it no separate growth or valuation credit.
Cybersecurity: Safend and the New SafeGenie Suite
In October, SuperCom introduced SafeGenie, a product suite that monitors and controls autonomous AI agents on endpoints. It builds on the kernel-level endpoint technology of Safend, the cybersecurity subsidiary. The company will sell it as a separate subscription to Safend's existing customers first, and then to its government customers and other enterprises.
"Since introducing SafeGenie, we have received requests for demos from channel partners and customers." — Ordan Trabelsi, President & CEO
Assessment: The product uses an existing customer base, which lowers the cost of a first test. The base is small, however: management put Safend's endpoint-security revenue at roughly $1 million. We treat SafeGenie as an option and do not include it in our 2027 revenue.
e-Government
The release describes the e-Government business (secure identification, biometric enrollment, document issuance and border control) only in its company description. No Q3 figures or contract updates were given.
Assessment: We assume no growth from e-Government. It is not part of the investment case.
Key KPIs
| KPI | Q1 2026 | Q2 2026 | Q3 2026 | Trend / read-through |
|---|---|---|---|---|
| U.S. EM quarterly recurring revenue growth (YoY) | 88% | 171% | About 255% | Faster growth from an undisclosed base |
| U.S. EM ARR growth (YoY run rate) | 180% (May/May) | 290% (July/July) | Not quantified | The ARR statistic is no longer given |
| New U.S. contracts since mid-2024 | More than 40 | More than 45 | More than 50 | Steady flow of wins |
| New U.S. states since mid-2024 | 16 | 19 | 21 | Illinois and Indiana added |
| GAAP gross margin | 63.1% | 60.4% | 49.8% | Two declines in a row; Q3 is the large one |
| Income tax benefit | $0.420M | $0.670M | $0.670M | Every 2026 quarter has one |
| Foreign-currency loss added back | $0.880M | $1.291M | $1.349M | Rising each quarter |
| Total shareholders' equity | n/a | $47.8M | $55.6M | July offering plus Q3 earnings |
Q1 2026 gross margin, tax benefit and currency addback are derived as nine-month or first-half totals less the later quarters.
Key Topics & Management Commentary
Overall Management Tone: Management was as confident as in Q2 and again framed the quarter around operating leverage and adjusted EBITDA. That framing fit the quarter less well than before: the prepared remarks read out a 49.8% gross margin and an operating loss without explaining either beyond the currency. Commentary on contracts and pipeline was specific, while commentary on margins and cash stayed general.
1. Gross Margin Fell to 49.8%, and the Call Named No Specific Cause
Gross margin fell to 49.8% from 60.4% in Q2 and 60.8% a year earlier. Cost of revenues rose $0.554 million sequentially while revenue fell $0.603 million. The company's gross-profit reconciliation adds back only amortization and stock compensation, so the currency loss does not explain the gross-margin decline on the company's own presentation.
"Our results continue to reflect the operating leverage in our model. As our programs mature and more monitoring units are deployed, upfront onboarding and deployment costs are spread across a growing recurring revenue base, and we are seeing that dynamic in our profitability, despite continued foreign currency headwinds from the stronger Israeli shekel." — Ordan Trabelsi, President & CEO (Q3 release)
The prepared remarks described the general margin mechanism: upfront onboarding, training, development and deployment costs at the start of a program, which later spread over a larger recurring base. That mechanism could explain a lower margin while Sweden and many U.S. programs start. Management did not make that link for Q3, however, and no question on the call addressed gross margin. Gross margin has also moved sharply before: it was 39.2% in Q4 2025 and 63.1% in Q1 2026.
Assessment: The decline may be launch-related and temporary, but the company has not shown that. A 1,060bp sequential fall in a quarter described as evidence of operating leverage reduces our confidence in management's margin commentary. We change Bull 2 to AT RISK and want a Q4 gross margin back near 60% before we restore it.
2. The Currency Addback Now Exceeds GAAP Operating Profit
Management attributed the operating loss mainly to a $1.349 million foreign-exchange loss, caused by the shekel's rise against the dollar. Most of SuperCom's operating costs are in shekels. The company adds this loss back in its non-GAAP operating profit, non-GAAP net income and EBITDA.
"The foreign currency loss reflected approximately a 10%, 11% year-over-year increase in the average value of the shekel against the U.S. dollar." — Ordan Trabelsi, President & CEO
The addback has risen each quarter this year: $0.880 million in Q1, $1.291 million in Q2 and $1.349 million in Q3. For nine months it totals $3.520 million, compared with GAAP operating profit of $1.796 million. The release text also cites "$0.38 million in additional costs" from the weaker dollar, but it does not reconcile that figure with the $1.349 million addback.
Assessment: If the addback measures the higher dollar cost of a shekel payroll, it is a normal operating cost while the shekel stays strong, not a one-time item. We therefore do not exclude it from the earnings that we value. It is the largest single item between the GAAP operating loss and company-defined EBITDA, ahead of depreciation and amortization.
3. Net Income Rests on a Deferred-Tax Benefit Again
SuperCom recognized a $0.670 million income tax benefit in Q3, the same amount as in Q2, after $0.420 million in Q1. The deferred-tax asset rose by exactly the nine-month benefit of $1.760 million, to $4.781 million. The benefit is a non-cash recognition of future tax value. It is not tax cash received.
"Our profitability and strong balance sheet also allow us to continue investing in our technology." — Ordan Trabelsi, President & CEO
Without the benefit, Q3 would show a net loss of ($0.616 million), equal to the pretax loss. Over nine months, the tax benefit equals 70.8% of GAAP net income ($1.760 million of $2.486 million). FY2025 followed the same pattern: the full $2.010 million tax benefit for that year came in Q4.
Assessment: A deferred-tax asset can be legitimate when management expects future taxable profit. It still supports reported earnings without adding cash, and four quarters in a row (counting Q4 2025's $2.010 million) make it a recurring part of the GAAP result. As in Q2, our estimates assume no further benefit. The cut to our FY2026 EPS comes from lower operating income, not from the tax assumption.
4. Trailing GAAP Operating Income Is Negative; Company EBITDA Is $12 Million
The release cites trailing twelve-month EBITDA of $12 million. Using the audited FY2025 statements less the nine-month 2025 comparatives, Q4 2025 had an operating loss of ($3.279 million), including $2.409 million of other operating expense. Added to the nine-month 2026 operating profit of $1.796 million, trailing GAAP operating income is a loss of about ($1.48 million) on revenue of $30.7 million.
"With strong profitability with a TTM EBITDA of $12 million, a strong balance sheet and a growing pipeline across the U.S. and Europe, we believe SuperCom is well positioned to continue scaling its recurring revenue base globally." — Ordan Trabelsi, President & CEO (Q3 release)
The difference of about $13.5 million is depreciation and amortization, currency, stock compensation and items the company calls one-time. FY2025's audited statements also recorded a $1.853 million provision for doubtful accounts and a $0.334 million inventory write-down.
Assessment: "Strong profitability" describes the adjusted measures, not the GAAP or cash results. We do not reject EBITDA as an operating signal, but we cannot value the company on a $12 million profit figure while trailing GAAP operating income is a loss. This is why Bear 2 moves to MATERIALIZING.
5. Revenue Grew 20%, and the Sequential Decline Was in the Estimates
Year-over-year growth of 20.3% was the fastest of the year. The 7.5% sequential decline was not a surprise to the estimate panels, which had expected Q3 revenue of $6.95 million to $7.20 million. It was a surprise to our own forecast, which assumed H2 revenue of $17.3 million.
"This is an inherent lag between contract signing and revenue recognition. For some contracts, full deployment can take 6 months or more as customers replace existing units." — Ordan Trabelsi, President & CEO
The company did not explain which programs drove the sequential decline. Q3 included European orders of more than $3 million, but the release does not say how much of that value was recognized in the quarter.
Assessment: The growth trend is intact on a year-over-year basis, and Bull 1 stays ON TRACK. Our FY2026 revenue estimate falls to $31.5 million from $33.0 million, because $33.0 million would now need $9.815 million in Q4.
6. U.S. Recurring Revenue Grew About 255%, but the ARR Figure Disappeared
The release gives quarterly U.S. EM recurring revenue growth of about 255%. In Q2, the company had also given ARR run-rate growth of 290% (July over July). This quarter it gave no ARR growth rate and no ARR dollar figure. On the call, the CEO referred listeners to the release.
"Our U.S. electronic monitoring technology annualized recurring revenue run rate increased significantly, as per the PR." — Ordan Trabelsi, President & CEO
Faster recurring growth with fewer metrics is a weaker disclosure, not a stronger one. Without a dollar base, a 255% rate can describe a small business growing quickly or a large one, and the two have very different value.
Assessment: We give credit for the direction. We still do not give the company a recurring-software multiple, because we cannot measure the recurring share of revenue. Absolute ARR remains the most useful single disclosure management could add.
7. Receivables Equal About 91% of a Year's Revenue
Unlike the Q2 release, the Q3 balance sheet shows long-term trade receivables on their own line: $12.882 million, up $3.268 million since December. With current receivables of $15.133 million, total trade receivables are $28.015 million. That is 91.3% of trailing revenue of $30.669 million.
"For larger European programs, device revenue may be recognized upfront and recorded as a receivable, which is collected over the life of the program. As those receivables are collected, cash flow improves even though the related revenue was recognized earlier." — Ordan Trabelsi, President & CEO
The new split also answers part of a Q2 question. Of the $11.122 million nine-month increase in combined long-term receivables and other non-current assets, $7.854 million is in other non-current assets and $3.268 million in long-term receivables. The release does not describe what the other non-current assets are. Current receivables fell $1.941 million from June, which is a modest positive.
Assessment: The receivables are partly a result of the European contract model, so their size is not by itself a sign of collection trouble. It does mean reported revenue runs well ahead of cash, and FY2025's $1.853 million doubtful-accounts provision shows that collection risk is real. We want long-term receivables to start declining as a share of revenue.
8. Cash Rose on the Offering; the Underlying Draw Slowed
Cash rose to $12.921 million from $7.429 million at June 30. The July offering raised about $7.05 million of estimated net proceeds. Excluding that, cash fell about $1.6 million in Q3, compared with a $4.766 million decline in cash and bank deposits in H1. Short-term credit fell $0.409 million, and trade payables fell $1.061 million. Paid-in capital rose $0.376 million more than the offering estimate and stock compensation explain; if that amount was also cash from share issuance, the underlying draw was about $1.9 million.
"Our outstanding long-term debt carries a blended interest rate of approximately 6% with no cash payments due until the end of 2028, providing flexibility to invest in our growth." — Ordan Trabelsi, President & CEO
Gross debt is $20.152 million and net debt about $7.2 million, consistent with management's figure of about $7 million. The long-term loan rose $0.423 million in the quarter, which suggests that interest accrues to the balance instead of being paid in cash. Total shareholders' equity rose to $55.6 million.
Assessment: The slower cash draw is the best balance-sheet news in the quarter, and the debt terms remove near-term repayment pressure. The audited FY2025 operating cash outflow of ($5.49 million) remains the last full-year evidence, however. Bear 1 stays MATERIALIZING because the July dilution is already in the per-share figures and the company still has no demonstrated cash surplus.
9. Sales Spending Rose 70%, and Management Says the Team Is Sufficient
Selling and marketing expense rose $0.442 million year over year to $1.076 million. The release attributes the increase to headcount added for future revenue growth. The U.S. sales team now has five people and the European team three or four, in addition to management and bid managers.
"We developed a team of five people in the U.S., sales team, and in Europe, we have, I think, roughly three or four people." — Ordan Trabelsi, President & CEO
Asked about 2027, management said the current team is sufficient "right now" and described AI tools that search for and compare bid opportunities. Total operating expenses were flat with Q2, but only because lower R&D and other expense offset a 9.6% sequential increase in selling and marketing and a 9.1% increase in G&A.
Assessment: The sales investment has bought a steady flow of contract wins. We model operating expenses of $4.1 million in Q4, 2.1% above Q3, and $16.8 million for FY2027, 6.9% above our FY2026 estimate. A larger increase without a margin recovery would weaken the case further.
10. Europe: Sweden's Range, New Orders, and the England Opportunity
Management repeated the Swedish program's value range and the published customer budget. It also restated the England opportunity of more than £150 million and said several European opportunities, including Italy, should come up for bid over the next 24 months. In Q2, the window had been 18 to 24 months.
"The total project value is estimated to range from $17 million, reflecting the previously announced base case scenario, to the $75 million budget published by the customer." — Ordan Trabelsi, President & CEO
"We believe we are now better positioned to compete for this U.K. contract and others like it." — Ordan Trabelsi, President & CEO
Management also cited a European win rate of more than 65%. It gave no Swedish revenue to date, no Swedish phasing and no England timing.
Assessment: Europe remains real optionality, supported by more than 20 national wins. None of the large opportunities has moved into our base case. Bull 3 stays ON TRACK, but Q3 added little new European evidence: the Ministry of Justice orders were announced in July, and we still need a Swedish revenue figure to measure conversion.
11. SafeGenie Adds an Option, Not a Forecast
SafeGenie checks each action an AI agent tries to take on an endpoint and allows, flags or blocks it under the customer's policy. Initial versions are close to deployment with several existing Safend customers. Management described the potential as large relative to Safend's current revenue.
"SafeGenie will be offered as a separate subscription alongside existing Safend licenses and maintenance agreements." — Ordan Trabelsi, President & CEO
"Electronic monitoring remains our primary growth driver, while SafeGenie allows us to build on the technology and customer relationships already within SuperCom." — Ordan Trabelsi, President & CEO
The inputs given on the call (500,000 to 1 million endpoints at $50 to $250 a year) describe a ceiling of $25 million to $250 million at full conversion. That is an installed-base calculation, not a revenue forecast, and management did not give one for 2027.
Assessment: The product is a low-cost test of a fast-growing security category. It also adds a second development priority at a time when the core business has a margin question to answer. We give it no value in our base case and will look for paid deployments before we do.
Guidance & Outlook
| Item | Q2 position | Q3 update | Our interpretation |
|---|---|---|---|
| FY2026 revenue / EPS guidance | No numeric range | No numeric range | Maintained (qualitative only) |
| U.S. deployments | Signed contracts to deploy further | New York rollout this month; Illinois training began in October; full deployment can take 6+ months | Supports 2027 more than Q4 |
| Margins | Further potential from mature programs and automation | Margin-expansion steps restated; no Q3 explanation | Credibility reduced by the Q3 decline |
| European pipeline | Procurements over 18 to 24 months | Bids over the next 24 months, including Italy | Timing is outside FY2026 |
| Sales capacity | Seeking Latin America and Asia-Pacific leadership | Current team sufficient "right now"; other regions under evaluation | Supports a modest operating-expense increase |
| SafeGenie | n/a | Initial versions for several existing customers | No revenue guidance |
SuperCom again gave no numerical guidance. Management described deployment timing and pipeline breadth, but it did not discuss the Q4 margin or revenue level.
Implied Q4 ramp: Our new FY2026 revenue estimate of $31.5 million needs $8.3 million in Q4. That is 10.9% above Q3 and 10.9% above Q4 2025. Our prior $33.0 million estimate would have needed $9.815 million, which we no longer consider credible.
Street at: The Q3 estimate panels sat below Q2 actuals. We did not find a verifiable full-year consensus.
Guidance style: Qualitative and consistent with prior quarters. The absence of numbers puts more weight on the reported margins, and in Q3 those margins went the wrong way.
Analyst Q&A Highlights
The question period was short. One analyst asked three questions, and none of them addressed the gross margin, the currency addback or cash flow.
What a Successful SafeGenie Launch Looks Like
The question asked whether SafeGenie could produce material revenue in 2027 and where demand would come from first. Management answered with the size of Safend's installed base and price points, not with a revenue expectation or a geography.
Q: "Should we see material revenue in 2027? And how does that look geographically? Do you expect it to be a pretty global product? Or where do you anticipate demand initially coming from?"
— Matthew Galinko, Maxim Group
A: "We have between 500,000 and 1 million endpoints at Safend, and revenue is roughly $1 million for these products of security. They charge between $50 to $250 a year. So it's roughly 50x or more, up to 50x, what we're currently getting from Safend, and that's just with the existing customer base, the potential. That's just the potential. Of course, we're not going to convert everyone to this product, but there's a huge potential there with our existing customer base."
— Ordan Trabelsi, President & CEO
Assessment: The answer sized the opportunity but did not address 2027 revenue. The useful new fact is Safend's current revenue of roughly $1 million, which shows how small the starting point is. We keep SafeGenie out of our estimates.
How the U.S. and European Pipelines Compare
The question asked how management compares the two pipelines and how the revenue mix could change depending on where the company wins. Management described a larger European contract ladder and a larger U.S. market where wins are displacing incumbents, but gave no mix target.
Q: "So how are you thinking about the respective pipelines and kind of where your mix goes depending on where you win?"
— Matthew Galinko, Maxim Group
A: "In Europe, we are at a larger scale. We started those projects at $100,000, $200,000. We went up to $1 million, $3 million, $5 million, $7 million, $33 million, and now up to $75 million. So, on both markets, we are effectively growing up the ladder and growing our customer base."
— Ordan Trabelsi, President & CEO
Assessment: The ladder shows how much the European contract sizes have grown. The $75 million figure is the Swedish customer's published budget, not a contract value, and the company's own base case is $17 million. Larger contracts can also increase the up-front cost and receivables burden that Q3 exposed.
Whether the U.S. Sales Team Needs to Grow in 2027
The question asked whether more U.S. sales headcount is needed to keep the momentum. Management said the current team is sufficient, linked the expense increase to the hires already made, and described a high win rate.
Q: "So looking into '27, particularly in the U.S. market, do you see an opportunity to grow the sales team to help further accelerate that business or sustain the momentum? Or does the existing headcount, is that sufficient for continuing the growth in the U.S.?"
— Matthew Galinko, Maxim Group
A: "Right now, it's sufficient. We saw an increase in expenses accordingly, and we think the team can do much more than we're seeing today."
— Ordan Trabelsi, President & CEO
Assessment: This is the closest the call came to a cost commitment, although management phrased it in the present tense. It supports our assumption of only a modest increase in operating expenses. If expenses rise sharply in 2027 without a matching margin recovery, the answer will have been too optimistic.
What They're NOT Saying
- Why gross margin fell 1,060bp: The release and call give the 49.8% margin but no cause by program, region or cost type. Without that, investors cannot tell a launch-cost dip from a lower margin structure.
- How the currency loss is measured: The release adds back $1.349 million but also cites $0.38 million of additional currency costs, and it does not reconcile the two. It also does not identify the expense line that holds the loss.
- Absolute ARR, and now the ARR growth rate too: Q2 gave ARR run-rate growth of 290%. Q3 gives only quarterly recurring revenue growth. The recurring share of revenue remains impossible to measure.
- Cash flow and collections: The release has no cash-flow statement and does not describe the $10.403 million of other non-current assets or the collection schedule for $12.882 million of long-term receivables.
- Swedish revenue to date: The program launched in June, but the company has not said how much revenue it has produced or how quickly volumes are rising.
- A view on Q4: Management gave no indication of Q4 revenue or margin. Q4 2025 had included $2.409 million of other operating expense, so the year-end close is a real risk for the full-year GAAP result.
Market Reaction
- Pre-print setup: SPCB closed November 11 at $8.62, down 4.8% YTD, 14.2% over twelve months and 7.8% over the prior 30 days. Its pre-print 52-week closing range was $7.20 to $12.36. The stock had already fallen 23.0% from the $11.20 close after the Q2 report.
- Reaction session, November 12: The shares opened at $8.51, traded between $6.30 and $8.60, and closed at $6.66, down 22.7%. The close was below the pre-print 52-week closing low.
- Volume and market: Volume was about 0.6 million shares, 12.9 times the 30-day average. The S&P 500 fell 0.4%.
- Next session, November 13: The shares fell another 7.4% to close at $6.17, after a low of $6.00, on about 0.23 million shares. The two-session decline was 28.4%.
Margin over revenue. The revenue beat did not support the stock. Contemporaneous coverage attributed the fall to the lower gross margin, the currency loss and the GAAP profit decline. The release came out before the open, yet the shares opened only 1.3% lower and fell during a session that included the 10 a.m. call. We cannot separate the weight of the statements and the call from trading data alone.
A thin float meets a quality question. Volume of 12.9 times normal in a stock that usually trades under 0.1 million shares a day shows how few holders can move the price. The continued decline on November 13 suggests that selling continued after the market had read the full release. A stock that moves 28% on a quarter with a revenue beat is pricing a change in the earnings-quality view, not a change in growth.
Where it leaves the valuation. At $6.17, the stock is 44.9% below the price at our Q2 downgrade and below the $7.00 value of our prior bear case. The market has moved faster than the fundamentals, but the fundamentals moved in the same direction.
Street Perspective
Debate: Is the Margin Decline Timing or Structure?
Bull view: New programs carry up-front costs, Sweden and many U.S. contracts started recently, and gross margin recovered from 39.2% to 63.1% between Q4 2025 and Q1 2026. A similar recovery is likely as deployments mature.
Bear view: Cost of revenues rose 54.0% against 20.3% revenue growth, and management did not explain why. A larger European device mix and rising support costs could make a lower margin the new normal.
Our take: The history of large swings supports the timing argument, but the company has not given the evidence. We assume 55% in Q4 and 57% in FY2027, below the H1 level, and treat a return to 60% as upside.
Debate: Which Profit Measure Should Set the Value?
Bull view: Company-defined EBITDA of $12 million over twelve months shows a profitable business. Currency and non-cash items hide that strength in the GAAP numbers.
Bear view: Trailing GAAP operating income is negative, net income depends on deferred-tax benefits, and FY2025 operating cash flow was negative. The adjusted figure excludes real costs.
Our take: The bear side has the stronger argument on this question. The currency cost is a real cost while the shekel stays strong, and cash flow has not confirmed the adjusted profit. We value the business on sales with a low multiple until GAAP and cash results improve.
Debate: Has the Selloff Already Priced the Risk?
Bull view: At $6.17 the stock trades near tangible book, at about 0.70 times total book and about 1.2 times our FY2027 revenue estimate, with net debt of only about $7 million and no cash debt payments due before the end of 2028.
Bear view: Tangible book is mostly receivables, a deferred-tax asset and other non-current assets of uncertain value. A company that needs equity to fund growth can trade below tangible book for a long time.
Our take: The selloff has taken the price below the $7.00 bear value we set in August, which is why we do not downgrade. It does not create enough upside to upgrade while the margin and cash questions remain open.
Our Estimates & Valuation
We have no published model for SuperCom. The figures below are our analyst estimates, compared with the estimates in our Q2 recap. They are not management guidance.
| Item | Prior estimate (Q2 recap) | New estimate | Reason |
|---|---|---|---|
| FY2026 revenue | $33.0M | $31.5M (+12.9%) | Q3 below our run rate; Q4E $8.3M |
| FY2026 gross margin | 60.8% | 57.1% | Q3 at 49.8%; Q4E 55% |
| FY2026 operating income | $4.265M | $2.261M | Q3 loss; Q4E $0.465M |
| FY2026 GAAP net income | $3.812M | $2.551M | Lower operating income; no Q4 tax benefit (as in Q2); $0.4M Q4 financial expense |
| FY2026 GAAP EPS | About $0.61 | About $0.44 | Nine-month $0.43 plus about $0.01 in Q4; about $0.40 on the prior 6.3M-share basis |
| FY2027 revenue | n/a | $35.0M (+11.2%) | Signed U.S. contracts deploy; no new national program |
| FY2027 operating income | n/a | $3.150M | 57% gross margin; $16.8M operating expenses |
| Valuation basis | 2.4x FY2026 sales | 1.4x FY2027 sales | Roll forward one year; lower multiple |
| Valuation shares | 7.0M | 7.0M | 6.28M basic plus allowance for equity-linked dilution |
The Q4 bridge: Q4 revenue of $8.3 million at a 55% gross margin gives $4.565 million of gross profit. Operating expenses of $4.1 million leave $0.465 million of operating income, and $0.4 million of net financial expense leaves $0.065 million of pretax income. With no tax benefit, FY2026 net income is $2.551 million, and FY2026 EPS is about $0.44. Each percentage point of Q4 gross margin changes pretax income by $0.083 million.
FY2027 at a glance: Revenue of $35.0 million at a 57% gross margin gives $19.950 million of gross profit. Operating expenses of $16.8 million leave $3.150 million of operating income, and $1.6 million of financial expense leaves $1.550 million of pretax income, or about $0.24 per share on 6.5 million shares. At $6.17, that is a high multiple of GAAP earnings, which is why we use sales.
Valuation method: We keep the equity-value-to-sales approach from the Q2 recap. Because FY2026 is three-quarters reported, we roll the base year to FY2027. We cut the multiple to 1.4 times from 2.4 times, because the Q3 margin removed the evidence for a recurring-revenue premium and trailing GAAP operating income is negative. At $6.17, the market values the shares at about 1.23 times our FY2027 revenue on 7.0 million shares. The same 1.4 times on FY2026 revenue gives $6.30, so the roll-forward adds about $0.70 a share.
| 12-month scenario | FY2027 revenue | Equity / sales | Valuation shares | Value / share | Return vs. $6.17 |
|---|---|---|---|---|---|
| Bear: margins stay near 50% and more equity is needed | $31M | 0.9x | 7.5M | $3.72 | -39.7% |
| Base: signed contracts deploy, margin partly recovers | $35M | 1.4x | 7.0M | $7.00 | +13.5% |
| Bull: margin returns to 60% and receivables collect | $39M | 2.0x | 7.0M | $11.14 | +80.6% |
The base calculation is $35 million x 1.4 / 7.0 million shares = $7.00, which is 38.1% below our Q2 base value of $11.31. We assume no dividend, so total return equals price return. As a cross-check, tangible equity (equity less goodwill, other intangibles and the patents line) is $37.1 million, or about $5.91 per basic share, and total equity is about $8.86 per share. Tangible equity still includes $28.0 million of trade receivables and a $4.8 million deferred-tax asset, so it is not a hard floor.
Rating consequence: The base case gives a return of +13.5%, only modestly above what we expect from the S&P 500, with a very wide range of outcomes. The bull case needs exactly the margin recovery that Q3 failed to show. The bear case is closer to the current evidence than its percentage suggests. Hold remains the right rating: the price no longer supports a downgrade, and the fundamentals do not yet support an upgrade.
Thesis Scorecard Post-Earnings
The standing thesis from our Q2 recap had three bull pillars and three bear points. We score the same six points below.
| Thesis point | Status | Notes |
|---|---|---|
| Bull 1: Sustained EM-led revenue growth | Confirmed (ON TRACK, unchanged) | Revenue +20.3% YoY; U.S. recurring revenue up about 255%. Sequential decline cut our FY2026 estimate to $31.5M. |
| Bull 2: High margins as deployments mature | Challenged (ON TRACK to AT RISK) | Gross margin 49.8% versus 60.4% in Q2; operating loss; no specific explanation. |
| Bull 3: European deployment and expansion | Neutral (ON TRACK, unchanged) | Little new evidence: the $3M+ Ministry of Justice orders were announced in July; Sweden live; still no Swedish revenue figure. |
| Bear 1: Financing and per-share dilution | Confirmed (MATERIALIZING, unchanged) | Non-GAAP EPS -23.1% on flat adjusted net income; no new raise; slower cash draw. |
| Bear 2: Earnings quality and cash conversion | Confirmed (EMERGING to MATERIALIZING) | Pretax loss; net income from a tax benefit; currency addback twice nine-month operating profit; receivables 91% of trailing revenue. |
| Bear 3: Concentrated orders and timing | Neutral (EMERGING, unchanged) | Sequential revenue decline without explanation; European orders remain lumpy. |
Overall: The thesis weakened. Revenue growth held, but one bull pillar moved to AT RISK and one bear point moved to MATERIALIZING. The quarter moved the debate from "how fast does SuperCom grow" to "how much of the growth becomes profit and cash".
Action: Hold. We would upgrade on a Q4 gross margin near 60%, with positive GAAP operating profit and net income that does not depend on a tax benefit, together with either absolute ARR disclosure or a decline in long-term receivables. A second quarter of gross margin below 55%, or a new equity raise near the current price, would move us toward Underperform.